Empirical Asset Management LLC Buys 4,204 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Empirical Asset Management LLC boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 656.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,844 shares of the biotechnology company’s stock after acquiring an additional 4,204 shares during the period. Empirical Asset Management LLC’s holdings in Axon Enterprise were worth $2,879,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Public Sector Pension Investment Board boosted its position in shares of Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares in the last quarter. CIBC Asset Management Inc boosted its holdings in shares of Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after buying an additional 895 shares in the last quarter. Foundations Investment Advisors LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $221,000. Sequoia Financial Advisors LLC increased its stake in shares of Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after acquiring an additional 81 shares in the last quarter. Finally, Axxcess Wealth Management LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter valued at $814,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $593.89 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a 50-day moving average of $617.37 and a 200-day moving average of $458.84. Axon Enterprise, Inc. has a one year low of $247.04 and a one year high of $698.67. The company has a market cap of $45.28 billion, a P/E ratio of 153.46, a P/E/G ratio of 5.71 and a beta of 1.04.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group boosted their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Needham & Company LLC increased their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Finally, Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $504.92.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Jeffrey C. Kunins sold 1,035 shares of the business’s stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the transaction, the insider now directly owns 124,243 shares in the company, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,545 shares of company stock valued at $30,721,337. Corporate insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.